Long intergenic non-protein coding RNA 2226 (LINC02226)

Long intergenic non-protein coding RNA 2226 (LINC02226) is classified as a long intergenic non-coding RNA (lincRNA), which are RNA molecules longer than 200 nucleotides that do not overlap annotated protein-coding genes[1][3][5]. lincRNAs, including LINC02226, are members of the long non-coding RNA (lncRNA) family, with functions that can include epigenetic regulation (e.g., recruitment of chromatin modification factors), transcriptional regulation, post-transcriptional modulation (such as RNA stability, splicing, or competing for microRNA binding), and occasionally impacting translation or post-translational processes[2][3][5]. Most lincRNAs have tissue-specific expression and may fine-tune gene regulation, but the specific biological role, disease association, or therapeutic relevance of LINC02226 itself remains uncharacterized in the current scientific literature[1][3]. There is currently no evidence that LINC02226 has been validated as a direct therapeutic target, disease biomarker, or that it directly interacts with any known drugs[1].

Other names

LINC02226